Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Rhodamine-modified fluorescent half-sandwich iridium and ruthenium complexes: potential application as bioimaging and anticancer agents.

Ma W, Guo L, Tian Z, Zhang S, He X, Li J, Yang Y, Liu Z.

Dalton Trans. 2019 Apr 9;48(15):4788-4793. doi: 10.1039/c9dt00999j.

PMID:
30892340
2.

Highly potent half-sandwich iridium and ruthenium complexes as lysosome-targeted imaging and anticancer agents.

Li J, Tian Z, Xu Z, Zhang S, Feng Y, Zhang L, Liu Z.

Dalton Trans. 2018 Nov 13;47(44):15772-15782. doi: 10.1039/c8dt02963f.

PMID:
30357192
3.

Half-Sandwich Iridium(III) and Ruthenium(II) Complexes Containing P^P-Chelating Ligands: A New Class of Potent Anticancer Agents with Unusual Redox Features.

Li J, Tian M, Tian Z, Zhang S, Yan C, Shao C, Liu Z.

Inorg Chem. 2018 Feb 19;57(4):1705-1716. doi: 10.1021/acs.inorgchem.7b01959. Epub 2018 Feb 5.

PMID:
29400963
4.

Half-Sandwich Iridium and Ruthenium Complexes: Effective Tracking in Cells and Anticancer Studies.

Li J, Guo L, Tian Z, Zhang S, Xu Z, Han Y, Li R, Li Y, Liu Z.

Inorg Chem. 2018 Nov 5;57(21):13552-13563. doi: 10.1021/acs.inorgchem.8b02161. Epub 2018 Oct 5.

PMID:
30289251
5.

Design, synthesis, and evaluation of fluorine and Naphthyridine-Based half-sandwich organoiridium/ruthenium complexes with bioimaging and anticancer activity.

Li J, Tian Z, Ge X, Xu Z, Feng Y, Liu Z.

Eur J Med Chem. 2019 Feb 1;163:830-839. doi: 10.1016/j.ejmech.2018.12.021. Epub 2018 Dec 12.

PMID:
30579123
6.

Serendipitous Synthesis of Five-Coordinated Half-Sandwich Aminoimine Iridium(III) and Ruthenium(II) Complexes and Their Application as Potent Anticancer Agents.

Du Q, Guo L, Ge X, Zhao L, Tian Z, Liu X, Zhang F, Liu Z.

Inorg Chem. 2019 Apr 15. doi: 10.1021/acs.inorgchem.9b00282. [Epub ahead of print]

PMID:
30986046
7.

Organoiridium complexes: anticancer agents and catalysts.

Liu Z, Sadler PJ.

Acc Chem Res. 2014 Apr 15;47(4):1174-85. doi: 10.1021/ar400266c. Epub 2014 Feb 20. Review.

8.

Novel and Versatile Imine-N-Heterocyclic Carbene Half-Sandwich Iridium(III) Complexes as Lysosome-Targeted Anticancer Agents.

Yang Y, Guo L, Tian Z, Gong Y, Zheng H, Zhang S, Xu Z, Ge X, Liu Z.

Inorg Chem. 2018 Sep 4;57(17):11087-11098. doi: 10.1021/acs.inorgchem.8b01656. Epub 2018 Aug 22.

PMID:
30133276
9.

Novel C,N-Cyclometalated Benzimidazole Ruthenium(II) and Iridium(III) Complexes as Antitumor and Antiangiogenic Agents: A Structure-Activity Relationship Study.

Yellol J, Pérez SA, Buceta A, Yellol G, Donaire A, Szumlas P, Bednarski PJ, Makhloufi G, Janiak C, Espinosa A, Ruiz J.

J Med Chem. 2015 Sep 24;58(18):7310-27. doi: 10.1021/acs.jmedchem.5b01194. Epub 2015 Sep 4.

PMID:
26313136
10.

Rhodium, iridium, and ruthenium half-sandwich picolinamide complexes as anticancer agents.

Almodares Z, Lucas SJ, Crossley BD, Basri AM, Pask CM, Hebden AJ, Phillips RM, McGowan PC.

Inorg Chem. 2014 Jan 21;53(2):727-36. doi: 10.1021/ic401529u. Epub 2014 Jan 7.

11.

Half-sandwich complexes of iridium and ruthenium containing cysteine-derived ligands.

Carmona M, Rodríguez R, Lahoz FJ, García-Orduña P, Cativiela C, López JA, Carmona D.

Dalton Trans. 2017 Jan 17;46(3):962-976. doi: 10.1039/c6dt04341k.

PMID:
28009875
12.

Synthesis and evaluation of new salicylaldehyde-2-picolinylhydrazone Schiff base compounds of Ru(II), Rh(III) and Ir(III) as in vitro antitumor, antibacterial and fluorescence imaging agents.

Palepu NR, Nongbri SL, Premkumar JR, Verma AK, Bhattacharjee K, Joshi SR, Forbes S, Mozharivskyj Y, Thounaojam R, Aguan K, Kollipara MR.

J Biol Inorg Chem. 2015 Jun;20(4):619-38. doi: 10.1007/s00775-015-1249-3. Epub 2015 Feb 25.

PMID:
25712889
13.

Organometallic Iridium(III) anticancer complexes with new mechanisms of action: NCI-60 screening, mitochondrial targeting, and apoptosis.

Hearn JM, Romero-Canelón I, Qamar B, Liu Z, Hands-Portman I, Sadler PJ.

ACS Chem Biol. 2013;8(6):1335-43. doi: 10.1021/cb400070a. Epub 2013 Apr 25.

14.

Synthesis and structural characterization of binuclear half-sandwich iridium, rhodium and ruthenium complexes containing 4,4'-dipyridyldisulfide (4DPDS) ligands.

Han YF, Li H, Fei Y, Lin YJ, Zhang WZ, Jin GX.

Dalton Trans. 2010 Aug 14;39(30):7119-24. doi: 10.1039/c0dt00057d. Epub 2010 Jul 1.

PMID:
20593103
15.

Dicarba-closo-dodecarborane-containing half-sandwich complexes of ruthenium, osmium, rhodium and iridium: biological relevance and synthetic strategies.

Barry NP, Sadler PJ.

Chem Soc Rev. 2012 Apr 21;41(8):3264-79. doi: 10.1039/c2cs15300a. Epub 2012 Feb 3. Review.

PMID:
22307021
16.

Pseudo electron-deficient organometallics: limited reactivity towards electron-donating ligands.

Pitto-Barry A, Lupan A, Zegke M, Swift T, Attia AAA, Lord RM, Barry NPE.

Dalton Trans. 2017 Nov 21;46(45):15676-15683. doi: 10.1039/c7dt02827j.

PMID:
28926052
17.

Half-sandwich iridium N-heterocyclic carbene anticancer complexes.

Wang C, Liu J, Tian Z, Tian M, Tian L, Zhao W, Liu Z.

Dalton Trans. 2017 May 30;46(21):6870-6883. doi: 10.1039/c7dt00575j.

PMID:
28405646
18.

Half-sandwich iridium(III) complexes with α-picolinic acid frameworks and antitumor applications.

Hao H, Liu X, Ge X, Zhao Y, Tian X, Ren T, Wang Y, Zhao C, Liu Z.

J Inorg Biochem. 2019 Mar;192:52-61. doi: 10.1016/j.jinorgbio.2018.12.012. Epub 2018 Dec 24.

PMID:
30597449
19.

Group 9 organometallic compounds for therapeutic and bioanalytical applications.

Ma DL, Chan DS, Leung CH.

Acc Chem Res. 2014 Dec 16;47(12):3614-31. doi: 10.1021/ar500310z. Epub 2014 Nov 4.

PMID:
25369127
20.

Computational properties of η6-toluene and η6-trifluorotoluene half-sandwich Ru(II) anticancer complexes.

Adeniyi AA, Ajibade PA.

J Biomol Struct Dyn. 2014;32(9):1351-65. doi: 10.1080/07391102.2013.819299. Epub 2013 Aug 1.

PMID:
23905613

Supplemental Content

Support Center